BlackRock Investment Management, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 51 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2015. The put-call ratio across all filers is 5.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2016$99,000
-44.1%
50,3170.0%0.00%
Q3 2016$177,000
-1.7%
50,317
+0.0%
0.00%
Q2 2016$180,000
-11.8%
50,314
+19.1%
0.00%
Q1 2016$204,000
-16.4%
42,241
+2.1%
0.00%
Q4 2015$244,000
-0.4%
41,3760.0%0.00%
Q3 2015$245,000
-57.2%
41,376
-1.7%
0.00%
-100.0%
Q2 2015$573,000
+262.7%
42,082
+240.6%
0.00%
Q1 2015$158,000
+79.5%
12,357
+44.4%
0.00%
Q4 2014$88,0008,5550.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$8,536,653,0002.90%
Glassman Wealth Services 72,366$137,0000.06%
B. Riley Wealth Management, Inc. 53,500$102,0000.02%
Sigma Planning Corp 223,400$424,0000.02%
Fore Capital, LLC 40,000$76,0000.02%
Psagot Value Holdings Ltd. 218,555$415,0000.02%
HBK Sorce Advisory LLC 85,500$162,0000.02%
WealthTrust Axiom LLC 10,000$19,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 12,894$24,0000.01%
Weiss Asset Management LP 29,691$56,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders